US2021040043A1PendingUtilityA1

Halogen substituted diketones, pyrazole compounds and processes for the manufacture of pyrazole compounds

Assignee: SOLVAYPriority: Jan 28, 2016Filed: Oct 23, 2020Published: Feb 11, 2021
Est. expiryJan 28, 2036(~9.5 yrs left)· nominal 20-yr term from priority
C07D 231/12C07D 231/18C07C 225/14
51
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The present invention concerns new halogen substituted diketone compounds, new pyrazole compounds, processes for the manufacture of pyrazole compounds and processes for the manufacture of agrochemical or pharmaceutical compounds.

Claims

exact text as granted — not AI-modified
1 .- 5 . (canceled) 
     
     
         6 . A compound of formula (VII) 
       
         
           
           
               
               
           
         
         wherein
 R 1  is selected from the group consisting of CF 2 Cl, CF 2 H, CFCl 2 , CFClH, CF 2 Br, CCl 3 , CF 3 , CBr 3 , and CI 3 ; 
 R 2  is CHal 3  wherein Hal is a halogen and each Hal is selected independently; 
 
         wherein, when R 2  is CF 3 , R 1  contains two, one or zero fluorine atoms or, when R 2  is CCl 3 , R 1  contains two, one or zero chlorine atoms,
 R 3  is selected from the group consisting of C 1 -C 12 -alkyl, C 2 -C 6  alkenyl, cycloalkyl, aryl, heteroaryl, and aralkyl; 
 R 4  is selected from the group consisting of H, X′, COOR′, OR′, SR′, C(O)NR′ 2 , wherein R′ are selected independently in C(O)NR′ 2  where R′ is hydrogen or a C 1 -C 12 -alkyl group, CN, C 1 -C 12 -alkyl, C 2 -C 6  alkenyl, aryl, cycloalkyl, aralkyl, heteroaryl, each of which is optionally substituted, and X′ is F, Cl, Br, or I. 
 
       
     
     
         7 .- 23 . (canceled) 
     
     
         24 . The compound according to  claim 6 , wherein R 2  is selected from the group consisting of CCl 3 , CF 3 , CBr 3 , and CI 3 . 
     
     
         25 . The compound according to  claim 24 , wherein R 2  is CCl 3 , CF 3 , or CBr 3 . 
     
     
         26 . The compound according to  claim 6 , wherein R 3  is CH 3 . 
     
     
         27 . The compound according to  claim 6 , wherein R 4  is H. 
     
     
         28 . The compound according to  claim 6 , wherein R 1  is CHF 2 , CClF 2 , CF 3 , or CCl 3 .

Join the waitlist — get patent alerts

Track US2021040043A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.